Basilea Pharmaceutica (XSWX:BSLN) Net Interest Margin (Bank Only) %


XSWX:BSLN Basilea Pharmaceutica Ltd XSWX:BSLN
62 GF Score
Price CHF53.40
GF Value CHF57.47
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Basilea Pharmaceutica Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

XSWX:BSLN
62GF Score
Basilea Pharmaceutica Ltd XSWX:BSLN
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Basilea Pharmaceutica (XSWX:BSLN) Overvalued in 2026?

Based on GuruFocus' analysis, Basilea Pharmaceutica stock appears to be undervalued. The current stock price of CHF53.40 is trading 7.1% below its estimated GF Value™ of CHF57.47. GuruFocus considers Basilea Pharmaceutica to be Fairly Valued.

Key valuation signals for XSWX:BSLN:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: CHF57.47 vs. price of CHF53.40 (7.1% below fair value)
  • GF Score™: 62/100 with 2 warning signs

No single metric tells the full story. See the XSWX:BSLN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Basilea Pharmaceutica Business Description

Address Hegenheimermattweg 167b, Allschwil, CHE, 4123
Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing drugs to meet the needs of patients with severe bacterial and fungal infections. The Company has operating subsidiaries in the United Kingdom and Germany. Geographically company derives revenue from Japan, Ireland, Republic of Korea, USA, Uruguay, Sweden, Canada, Jordan, Switzerland and Other countries.
62GF Score

Get the complete analysis for XSWX:BSLN

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF53.40
Price
CHF57.47
GF Value